Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2015 1
2016 9
2017 17
2018 11
2019 2
2020 4
2021 2
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean uroosaibrahim (2 results)?
Peritransplantation Use of Ruxolitinib in Myelofibrosis.
Ibrahim U, Petrone GEM, Mascarenhas J, Keyzner A. Ibrahim U, et al. Biol Blood Marrow Transplant. 2020 Dec;26(12):2177-2180. doi: 10.1016/j.bbmt.2020.08.015. Epub 2020 Aug 18. Biol Blood Marrow Transplant. 2020. PMID: 32818555 Free article. Review.
Immunotherapy-induced autoimmune hypophysitis.
Valecha G, Pant M, Ibrahim U, Atallah JP. Valecha G, et al. Among authors: ibrahim u. J Oncol Pharm Pract. 2019 Jan;25(1):217-220. doi: 10.1177/1078155217727142. Epub 2017 Aug 21. J Oncol Pharm Pract. 2019. PMID: 28825378
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M, Epperla N, Ghobadi A, Liu J, Lazaryan A, Ibrahim U, Jacobson CA, Naik SG, Nastoupil L, Chowdhury SM, Voorhees TJ, Jacobs MT, Farooq U, Osman K, Olszewski AJ, Ahmed S, Evens AM. McKenna M, et al. Among authors: ibrahim u. Br J Haematol. 2023 Jul;202(2):248-255. doi: 10.1111/bjh.18828. Epub 2023 May 2. Br J Haematol. 2023. PMID: 37129856
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Desai SH, Spinner MA, David K, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Arai S, Chang C, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Murphy J, Ansell S, Jagadish D, Orellana-Noia V, Diefenbach C, Iyenger S, Rappazzo KC, Mishra R, Choi Y, Nowakowski GS, Advani RH, Micallef IN. Desai SH, et al. Among authors: ibrahim u. Am J Hematol. 2023 Mar;98(3):464-471. doi: 10.1002/ajh.26827. Epub 2023 Jan 11. Am J Hematol. 2023. PMID: 36629030 Free article.
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Desai SH, Spinner MA, Evens AM, Sykorova A, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Michalka J, Ansell SM, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Arai S, Nowakowski GS, Mocikova H, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Prochazka V, Advani RH, Micallef I. Desai SH, et al. Among authors: ibrahim u. Blood Adv. 2023 Dec 12;7(23):7295-7303. doi: 10.1182/bloodadvances.2023011205. Blood Adv. 2023. PMID: 37729621 Free PMC article.
45 results